Ginkgo Bioworks Holdings (DNA) Net Cash Flow: 2020-2025
Historic Net Cash Flow for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -$94.5 million.
- Ginkgo Bioworks Holdings' Net Cash Flow rose 17.24% to -$94.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$504.9 million, marking a year-over-year decrease of 16.60%. This contributed to the annual value of -$383.6 million for FY2024, which is 1.09% down from last year.
- Latest data reveals that Ginkgo Bioworks Holdings reported Net Cash Flow of -$94.5 million as of Q3 2025, which was up 9.36% from -$104.2 million recorded in Q2 2025.
- Ginkgo Bioworks Holdings' Net Cash Flow's 5-year high stood at $1.5 billion during Q3 2021, with a 5-year trough of -$250.4 million in Q1 2025.
- Moreover, its 3-year median value for Net Cash Flow was -$104.2 million (2025), whereas its average is -$110.2 million.
- Per our database at Business Quant, Ginkgo Bioworks Holdings' Net Cash Flow surged by 113.33% in 2022 and then tumbled by 557.67% in 2023.
- Quarterly analysis of 5 years shows Ginkgo Bioworks Holdings' Net Cash Flow stood at -$172.4 million in 2021, then spiked by 113.33% to $23.0 million in 2022, then plummeted by 557.67% to -$105.1 million in 2023, then spiked by 47.00% to -$55.7 million in 2024, then increased by 17.24% to -$94.5 million in 2025.
- Its Net Cash Flow was -$94.5 million in Q3 2025, compared to -$104.2 million in Q2 2025 and -$250.4 million in Q1 2025.